Back to Search
Start Over
Durvalumab and multiple sclerosis: a causal link or simple unmasking?
- Source :
-
European journal of clinical pharmacology [Eur J Clin Pharmacol] 2020 Dec; Vol. 76 (12), pp. 1773-1774. Date of Electronic Publication: 2020 Jul 13. - Publication Year :
- 2020
- Subjects :
- Adenocarcinoma of Lung drug therapy
Brain diagnostic imaging
Humans
Lung Neoplasms drug therapy
Magnetic Resonance Imaging
Male
Middle Aged
Multiple Sclerosis chemically induced
Multiple Sclerosis immunology
Antibodies, Monoclonal adverse effects
Immune Checkpoint Inhibitors adverse effects
Multiple Sclerosis diagnosis
Subjects
Details
- Language :
- English
- ISSN :
- 1432-1041
- Volume :
- 76
- Issue :
- 12
- Database :
- MEDLINE
- Journal :
- European journal of clinical pharmacology
- Publication Type :
- Report
- Accession number :
- 32661572
- Full Text :
- https://doi.org/10.1007/s00228-020-02959-0